Developmentally regulated SMAD2 and SMAD3 utilization directs activin signaling outcomes

Developmental Dynamics

Volumn 238, Issue 7, 2009, Pages 1688-1700

  Itman, Catherine ^a,b   Small, Chris ^c   Griswold, Michael ^c   Nagaraja, Ankur K ^d   Matzuk, Martin M ^d   Brown, Chester W ^d   Jans, David A ^a,b   Loveland, Kate L ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Development; Gja1; Morphogen gradient; PDGF; Rarres1; Serpina5; Sertoli; Testis; TGF ; TIG 1

Indexed keywords

ACTIVIN; SMAD2 PROTEIN; SMAD3 PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GJA1 GENE; MALE FERTILITY; MICROARRAY ANALYSIS; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SERPINA5 GENE; SERTOLI CELL; SIGNAL TRANSDUCTION; TESTIS DEVELOPMENT; TRANSGENIC MOUSE;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SERTOLI CELLS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN;

MUS MUSCULUS;

EID: 67649594906     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21995     Document Type: Article

References (57)

1. Anway MD, Show MD, Zirkin BR. 2005. Protein C inhibitor expression by adult rat Sertoli cells: effects of testosterone withdrawal and replacement. J Andrology 26:578-585. (Pubitemid 41161317)
2. Argentaro A, Sim H, Kelly S, Preiss S, Clayton A, Jans DA, Harley VR. 2003. A SOX9 defect of calmodulin-dependent nuclear import in campomelic dysplasia/ autosomal sex reversal. J Biol Chem 278: 33839-33847. (Pubitemid 37553218)
3. Barakat B, O'Connor AE, Gold E, de Kretser DM, Loveland KL. 2008. Inhibin, activin, follistatin and follicle stimulating hormone serum levels and testicular production are highly modulated during the first spermatogenic wave in mice. Reproduction 136:345-359.
4. Betscholtz C, Karlsson L, Lindahl P. 2001. Developmental roles of platelet-derived growth factors. Bioessays 23:494-507. (Pubitemid 32575610)
5. Boitani C, Stefanini M, Fragale A, Morena AR. 1995. Activin stimulates Sertoli cell proliferation in a defined period of rat testis development. Endocrinology 136: 4538-5444.
6. Bollenbach T, Pantazis P, Kicheva A, Bokel C, Gonzalez-Gaitan M, Julicher F. 2008. Precision of the Dpp gradient. Development 135:1137-1146. (Pubitemid 351578142)
7. Brehm R, Zeiler M, Ruttinger C, Herde K, Kibschull M, Winterhager E, Willecke K, Guillou F, Lecureuil C, Steger K, Konrad L, Biermann K, Failing K, Bergmann M. 2007. A Sertoli cell-specific knockout of connexin43 prevents initiation of spermatogenesis. Am J Path 171:19-31. (Pubitemid 47339223)
8. Brown CW, Houston-Hawkins DE, Woodruff TK, Matzuk MM. 2000. Insertion of Inhbb into the Inhba locus rescues the Inhbanull phenotype and reveals new activin functions. Nat Genet 25:453-457. (Pubitemid 32983442)
9. Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, Arias A, Paris R, Tortosa A, Mora J, Baselga J, Seoane J. 2007. High TGF-beta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11:147-160. (Pubitemid 46209848)
10. Buzzard JJ, Farnworth PG, de Kretser DM, O'Connor AE, Wreford NG, Morrison JR. 2003. Proliferative phase Sertoli cells display a developmentally regulated response to activin in vitro. Endocrinology 144:474-483. (Pubitemid 36205218)
11. Buzzard JJ, Loveland KL, O'Bryan MK, O'Connor AE, Bakker M, Hayashi T, Wreford NG, Morrison JR, de Kretser DM. 2004. Changes in circulating and testicular levels of inhibin A and B and activin A during postnatal development in the rat. Endocrinology 145:3532-3541. (Pubitemid 38830025)
12. Chang H, Brown CW, Matzuk MM. 2002. Genetic analysis of the mammalian Transforming growth factor-beta superfamily. Endocr Rev 23:L787-L823. (Pubitemid 35454589)
13. de Winter JP, Themmen APN, Hoogerbrugge JW, Klaij IA, Grootegoed JA, de Jong FH. 1992. Activin receptor mRNA expression in rat testicular cell types. Mol Cell Endocrinol 83:R1-R8.
14. de Winter JP, Vanderstichele HMJ, Verhoeven G, Timmerman MA, Wesseling JG, de Jong FH. 1994. Peritubular myoid cells from immature rat testes secrete activin A and express activin receptor type II in vitro. Endocrinology 135:759-767. (Pubitemid 24241260)
15. Dyson S, Gurdon JB. 1998. The interpretation of position in a morphogen gradient as revealed by occupancy of activin receptors. Cell 93:557-568. (Pubitemid 28240717)
16. Fragale A, Puglisi R, Morena AR, Stafanini M, Boitani C. 2001. Age-dependent activin receptor expression pinpoints activin A as a physiological regulator of rat Sertoli cell proliferation. Mol Hum Reprod 7:1107-1114. (Pubitemid 33150205)
17. Gnessi L, Emidi A, Jannini EA, Carosa E, Maroder M, Arizzi M, Ulisse S, Spera G. 1995. Testicular development involves the spatiotemporal control of PDGFs and PDGF receptors gene expression and action. J Cell Biol 131:1105-1121.
18. Goldman DR, Gruenbaum Y, Moir RD, Shumaker DK, Spann TP. 2002. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 16:533-547. (Pubitemid 34212486)
19. Grimm OH, Gurdon JB. 2002. Nuclear exclusion of Smad2 is a mechanism leading to loss of competence. Nat Cell Biol 4:519-522. (Pubitemid 34752438)
20. Heldin CH, Miyazono K, ten Dijke P. 1997. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471.
21. Hu JS, Doan LT, Currle DS, Paff M, Rheem JY, Schreyer R, Robert B, Monuki ES. 2008. Border formation in a Bmp gradient reduced to single dissociated cells. Proc Natl Acad Sci U S A 105:3398-3403. (Pubitemid 351723564)
22. Incorvaia L, Badalamenti G, Rini G, Arcara C, Fricano S, Sferazza C, di Trapani D, Gebbia N, Leto G. 2007. MMP-2, MMP-4 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. Anticancer Res 27:1519-1525. (Pubitemid 46807231)
23. Inman GJ, Nicolas FJ, Hill CS. 2002. Nucleocytoplasmic shuttling of Smads 2, 3 and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10:283-294. (Pubitemid 35007343)
24. Itman C, Loveland KL. 2008. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. Dev Dyn 237:97-111.
25. Itman C, Mendis S, Barakat B, Loveland KL. 2006. All in the family: transforming growth factor beta family action in testis development. Reproduction 132:233-246. (Pubitemid 44269705)
26. Jing C, El-Ghany MA, Beesley C, Foster CS, Rudland PS, Smith P, Ke Y. 2002. Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity. J Natl Cancer Inst 94:482-490. (Pubitemid 34411286)
27. Kaipia A, Penttila T-L, Shimasaki S, Ling N, Parvinen M, Toppari J. 1992. Expression of Inhibin beta-A and beta-B, follistatin and activin A receptor messenger ribonucleic acids in the rat seminiferous epithelium. Endocrinology 131:2703-2710.
28. Kim SG, Kim HA, Jong HS, Park JH, Kim NK, Hong SH, Kim TY, Bant YJ. 2005. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 15:4672-4683. (Pubitemid 41416450)
29. Kretschmer A, Moepert K, Dames S, Sternberger M, Kaufmann J, Klippel A. 2003. Differential regulation of TGF-beta signalling through Smad2, Smad3 and Smad4. Oncogene 22:6748-6763. (Pubitemid 37372215)
30. Labbe E, Silvestri C, Hoodless PA, Wrana JL, Attisano L. 1998. Smad2 and Smad3 positively and negatively regulate TGFbeta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol Cell 2:109-120. (Pubitemid 128378972)
31. Levay K, Slepak VZ. 2005. Tescalcin is an essential factor in megakaryocytic differentiation associated with Ets family gene expression. J Clin Invest 117:2672-2683.
32. Li Q, Graff JM, O'Connor AE, Loveland KL, Matzuk MM. 2007. SMAD3 regulates gonadal tumorigenesis. Mol Endocrinol 21:2472-2486. (Pubitemid 47529359)
33. Looyenga BD, Hammer GD. 2007. Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery. Mol Endocrinol 21:2440-2457. (Pubitemid 47529357)
34. Loveland KL, Zlatic K, Stein-Oakley A, Risbridger G, de Kretser DM. 1995. Platelet-derived growth factor ligand and receptor subunit mRNA in the Sertoli cell and Leydig cells of the rat testis. Mol Cell Biol 108:155-159.
35. Massague J, Seoane J, Wotton D. 2005. Smad transcription factors. Genes Dev 19:2783-2810. (Pubitemid 41739965)
36. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. 1992. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360:313-319. (Pubitemid 23000668)
37. Meehan T, Schlatt S, O'Bryan M, de Kretser DM, Loveland KL. 2000. Regulation of germ cell and Sertoli cell development by activin, follistatin and FSH. Dev Biol 220:225-237. (Pubitemid 30228149)
38. Mizuiri H, Yoshida K, Toge T, Oue N, Aungg PP, Noguchi T, Yasui W. 2005. DNA methylation of genes linked to retinoid signalling in squamous cell carcinoma of the esophatus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage. Cancer Sci 96:571-577. (Pubitemid 41488420)
39. Nagpal S, Patel S, Asano AT, Johnson AT, Duvic M, Chandraratna RA. 1996. Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin. J Invest Dermatol 106:269-274. (Pubitemid 26096423)
40. Perera EM, Martin H, Seeherunvong T, Kos L, Hughes IA, Hawkins JR, Berkovitz GD. 2001. Tescalcin, a novel gene endoding a putative EF-Hand Ca2+ binding protein, Col9a3 and Renin are expressed in the mouse testis during the early stages of gonadal differentiation. Endocrinology 142:455-463. (Pubitemid 32183708)
41. Pfaffl MW. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29:e45.
42. Piek E, Ju WJ, Heyer J, Escalante-Alcalde D, Stewart CL, Weinstein M, Deng C, Kucherlapati R, Bottinger EP, Roberts AB. 2001. Functional characterization of transforming growth factor beta signalling in Smad2- and Smad3- deficient fibroblasts. J Biol Chem 276:19945-19953. (Pubitemid 37411058)
43. Piperno G, LeDizet M, Chang XJ. 1987. Microtubules containing acetylated alpha-tubulin in mammalian cells in culture. J Cell Biol 104:289-302.
44. Rosner M, Freilinger A, Hengstschlager M. 2007. Akt regulates nuclear/cytoplasmic localization of tuberin. Oncogene 24: 521-531. (Pubitemid 46160966)
45. Saka Y, Hagemann AI, Piepenburg O, Smith JC. 2007. Nuclear accumulation of Smad complexes occurs only after the midblastula transition in Xenopus. Development 134:4209-4218.
46. Sridharan S, Simon L, Meling DD, Cyr DG, Gutstein DE, Fishman GI, Guillou F, Cooke P. 2007. Proliferation of adult Sertoli cells following conditional knockout of the gap junction progein GJA1 (Connexin43) in mice. Biol Reprod 76:804-812. (Pubitemid 46651221)
47. Suzuki T, Hasso SM, Fallon JF. 2008. Unique SMAD1/5/8 activity at the phalanx-forming region determines digit identity. Proc Natl Acad Sci U S A 105: 4185-4190. (Pubitemid 351754355)
48. Taplin M. 2008. Androgen receptor: role and novel therapeutic prospects in prostate cancer. Exp Rev Anticancer Ther 8:1495-1508.
49. Uemura M, Swenson ES, Gaca MDA, Giordano FJ, Reiss M, Wells RG. 2005. Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol Cell Biol 16:4214-4224. (Pubitemid 41262890)
50. Uhrin P, Dewerchin M, Hilpert M, Chrenek P, Schofer C, Zechmeister-Machhart M, Kronke G, Vales A, Carmeliet P, Binder BR, Geiger M. 2000. Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility. J Clin Invest 106:1531-1539. (Pubitemid 32038590)
51. Verbruggen LA, Salomon DS. 1980. Glucocorticoid receptors and inhibition of neonatal mouse dermal fibroblast growth in primary culture. Arch Dermatol Res 269:111-126. (Pubitemid 11241317)
52. Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL, Robertson EJ. 1998. Smad2 signaling in the extraembrynoic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92:797-808. (Pubitemid 28155318)
53. Wilson CL, Sims AH, Howell A, Miller CJ, Clarke RB. 2006. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer 13:617-628. (Pubitemid 43886681)
54. Wu CC, Shyu RY, Chou JM, Jao SW, Chao PC, Kang JC, Wu ST, Huang SL, Jiang SY. 2006. RARRES1 expression is significantly related to tumour differentiation and staging in colorectal adenocarcinoma. Eur J Cancer 42:557-565. (Pubitemid 43227937)
55. Yang YC, Piek E, Zavadil J, Liang D, Xie D, Heyer J, Pavlidis P, Kucherlapati R, Roberts AB, Bottinger EP. 2003. Hierarchical model of gene regulation by transforming growth factor beta. Proc Natl Acad Sci U S A 100:10269-10274. (Pubitemid 37071868)
56. Youssef EM, Chen XQ, Higuchi E, Kondy Y, Garcia-Manero G, Lotan R, Issa JP. 2004. Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers. Cancer Res 64:2411-2417. (Pubitemid 38523894)
57. Zhu Y, Richardson JA, Parada LF, Graff JM. 1998. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94:703-714. (Pubitemid 28436003)